Article Information
History
- June 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- E. Braybrook1,2,*,
- S. Pandey1,*,
- E. Vryonis3,
- N.R. Anderson1,
- L. Young2 and
- D.K. Grammatopoulos1,2,#
- 1Institute of Precision Diagnostics and Translational Medicine, Pathology, UHCW NHS Trust, Coventry, UK
- 2Translational Medicine, Warwick Medical School, Coventry, UK
- 3Infectious Diseases, UHCW NHS Trust, UK
- ↵#Corresponding author: [DKG] Clinical Sciences Research Laboratories, University Hospital of Coventry and Warwickshire; Clifford Bridge Road Coventry CV2 2DX, United Kingdom; Phone:0 2476968661; E-mail: D.Grammatopoulos{at}warwick.ac.uk
↵* equal co-authors
Posted June 21, 2021.
Screening for the alpha variant of SARS-CoV-2 (B.1.1.7) the impact of this variant on circulating biomarkers in hospitalised patients
